Winship Invest$ names pilot grant awardees

Eighteen investigators will receive a total of $820,000 in funding for new cancer research projects through Winship Invest$, a peer-reviewed program designed to fund novel, innovative cancer research at Winship Cancer Institute of Emory University.

Arriola appointed dean of Emory’s Laney Graduate School

Kimberly Jacob Arriola, PhD, MPH, executive associate dean for academic affairs in the Rollins School of Public Health and Charles Howard Candler Professor of Behavioral, Social and Health Education Sciences, has been appointed dean of the Laney Graduate School. She will also join the Office of the Provost leadership team as vice provost for graduate affairs.

Meltzer honored with Distinguished Investigator Award

Carolyn Meltzer, MD, FACR, has been selected for the 2021 Distinguished Investigator Award from the Academy for Radiology and Biomedical Imaging Research. Meltzer and fellow awardees will be recognized during the annual meeting of the Radiological Society of North America (RSNA), taking place Nov. 28 to Dec. 2, in Chicago.

Read Announcement

Juneteenth event to feature Dr. Marion Hood

In 1959, Emory School of Medicine rejected applicant Marion Hood because of his race. On June 17, the school will formally apologize to Hood and invite him to share his story during a virtual Juneteenth event, “Giving Voice: The Rest of His Story with Dr. Marion Hood." (Photo via Fox 5 News.)

National Black Family Cancer Awareness Week

The FDA Oncology Center of Excellence will host, “National Black Family Cancer Awareness Week: Engaging the Generations," on July 17 from 2 to 3:30 p.m. Panelists include Drs. Otis Brawley, Brian M. Rivers, John Carpten, and Robert Winn.

Teng joins Department of Hematology and Medical Oncology

Yong Teng, PhD, has joined Winship as an associate professor in Emory School of Medicine's Department of Hematology and Medical Oncology. His research interests include tumor microenvironment, tumor metabolism, and metastasis as well as a focus on translating these scientific discoveries into better cancer treatments.

View Profile

National Academies release new report on radioactive sources

Deborah Bruner, RN, PhD, FAAN, contributed to “Radioactive Sources: Applications and Alternative Technologies,” a report from the National Academies of Sciences, Engineering, and Medicine. The report, published June 14, offers insights into radiation therapy, global health, and radiation security in research.

Winship participates in AACI/AACR Virtual Hill Day

Drs. Suresh Ramalingam, Kimberly Kerstann, and Larry Boise participated in AACI/AACR Virtual Hill Day on June 9. The annual event, which advocates for cancer research federal funding, is organized by the Association of American Cancer Institutes (AACI) and American Associate for Cancer Research (AACR).

About Hill Day

Emory Johns Creek Hospital completes expansion project

Emory Johns Creek Hospital has completed a facility expansion that adds two new floors, 40 additional beds, a new parking deck, and approximately 70,000 square feet to the existing patient tower. A ribbon cutting was held at the hospital on June 10 to commemorate the expansion.

Webinar: "Trends in Metastatic Breast Cancer"

Kevin Kalinsky, MD, MS, will discuss updates in metastatic triple negative breast cancer during a free webinar on June 15 at noon. Hosted by Menarini Silicon Biosystems, the webinar will include a talk from Cecilia Simonelli, MD, on the clinical utility of circulating tumor cells.

Prostate cancer: Talking to people about your diagnosis

After a prostate cancer diagnosis, many men find it hard to talk about it or to reach out for help and support as they navigate their cancer journey. Christopher Filson, MD, MS, spoke with WebMD about these challenges and different ways to benefit from a support network.

Below are four selected Winship publications out of 59 published over the past week:

Smith KR, Brown JT, Wan L, Liu Y, Russler G, Yantorni L, Caulfield S, Lafollette J, Moore M, Kucuk O, Carthon B, Nazha B, Bilen MA. Clinical Outcomes and Racial Disparities in Metastatic Hormone-Sensitive Prostate Cancer in the Era of Novel Treatment Options. The Oncologist. 2021; PubMed PMID: 34096667.

View in PubMed

Michalski JM, Janss AJ, Vezina LG, Smith KS, Billups CA, Burger PC, Embry LM, Cullen PL, Hardy KK, Pomeroy SL, Bass JK, Perkins SM, Merchant TA, Colte PD, Fitzgerald TJ, Booth TN, Cherlow JM, Muraszko KM, Hadley J, Kumar R, Han Y, Tarbell NJ, Fouladi M, Pollack IF, Packer RJ, Li Y, Gajjar A, Northcott PA. Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy with Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma. Journal of Clinical Oncology: official journal of the American Society of Clinical Oncology. 2021; :JCO2002730. PubMed PMID: 34110925.

View in PubMed

Zhang XF, Xue F, Dong DH, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Lv Y, Maithel SK, Pawlik TM. New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data Analysis. Annals of Surgery. 2021; 274(1):e28-e35. PubMed PMID: 31356277.

View in PubMed

Zhang W, Anyalebechi JC, Ramonell KM, Chen CW, Xie J, Liang Z, Chihade DB, Otani S, Coopersmith CM, Ford ML. TIGIT modulates sepsis-induced immune dysregulation in mice with preexisting malignancy. JCI Insight. 2021; 6(11). PubMed PMID: 34100383.

View in PubMed